Submitted by: Submitted by serenapeter
Views: 10
Words: 522
Pages: 3
Category: Business and Industry
Date Submitted: 11/07/2016 04:56 AM
Global Ophthalmic Drugs Market to Reach Worth USD
27.6 Bn by 2022: Credence Research
According to the latest report published by Credence Research, Inc. “Ophthalmic Drugs Market –
(Prescription Type – Prescription Ophthalmic Drugs and Over the Counter (OTC) Drugs; Therapeutic Type:
Glaucoma Ophthalmic Drugs, Retinal Disorder Ophthalmic Drugs, Dry Eye Ophthalmic Drugs and Allergic
Conjunctivitis): Market Growth, Future Prospects and Competitive Analysis, 2016-2022,” the market was
valued at USD 17.2 Bn in 2015, and is expected to reach USD 27.6 Bn by 2022, expanding at a CAGR of
7.0% from 2016 to 2022.
Browse the full report Ophthalmic Drugs Market Growth, Future Prospects and Competitive Analysis,
2016-2022 report at http://www.credenceresearch.com/report/ophthalmic-drugs-market
Market Insights
Globally, average life expectancy has been increasing and it’s posturing medical issues within the
ophthalmology field. Among the elderly population, vision loss is a major healthcare problem. The growing
prevalence of eye–related disorders has created huge scope for ophthalmic drugs. Moreover, new
technologies combining drugs and device therapies are contributing significantly towards the
development of ophthalmic drugs market. North America accounted for the largest market in the
ophthalmic drugs market due to the rising number of patient population suffering from ocular diseases in
the region. The prevalence of blindness and vision impairment and other eye related disorders is expected
to increase rapidly among all age group, gender and racial group in North America. Asia Pacific ophthalmic
drug market holds high growth potential in near future due to factors such as rising geriatric population,
rising investments in healthcare infrastructure and increasing prevalence of ocular diseases.
Browse All Reports of This Category @ http://www.credenceresearch.com/industry/pharmaceuticalsmarket
The ophthalmic drug industry can be classified into...